Packed full of micro-RNA and other short-fragmented RNA sequences that are crucial for cell-to-cell communication, exosomes have recently become a critical factor in pathology and disease progression. Although seemingly difficult to study due to their low abundance, small size and delicateness, exosomes are present all throughout the human body, purified from various sample types such as plasma, serum, urine, amniotic fluid, cerebrospinal fluid (CSF) and saliva. In this blog, we present to you 3 commonly encountered issues surrounding exosome purification, along with our suggestions and solutions for these uncertainties.
Low Yield
Due to exosomes existing in low abundance within liquid biopsy, the purification of these extracellular vesicles can be quite difficult. Via our proprietary isolation technology, Norgen is able to purify the highest quantities of exosomes from samples for downstream applications, such as Western blot, Nanosight (NTA), Electron Microscopy, and RNA purification, without impacting the integrity or contents of the exosomes.
This is evidenced by a 2020 paper by Reale, et al. where they demonstrated that Norgen’s exosome purification kit obtained superior amounts of extracellular vesicles (EVs) and further confirmed that these EVs were indeed exosomes by correlating this finding with levels of exosome specific protein TSG101. This is further supported by the co-founder and chief scientist at Cancer Treatment Options and Management Inc. (CTOAM), Alex Rolland, who was having issues with isolation quantity before switching to Norgen’s product; “Recently Norgen has worked with us to purify blood-based exosomes and exosomal-RNA at a high enough concentration to allow RNA seq based expression testing… we are able to obtain expression of 20,000 genes from tumour associated exosomes from cancer patients both in remission and experiencing recurrence.” commented Alex Rolland from CTOAM.
Contamination
Exosomes often co-purify with other extracellular vesicles and related structures as they are similar in size. This contaminates the exosome purity and can affect downstream applications as well as confidence in the results. Many popular methods of exosome purification, such as ultracentrifugation, precipitation, and filtration, are size-based and therefore suffer from such contamination. Particularly, the industry-standard ultracentrifugation often results in a single pellet containing everything, including small vesicles, total RNA and small RNA, tediously leading to contaminated outcomes. Similar issues also occur with polyethylene glycol (PEG) precipitation, which is found in many popular commercial kits. Norgen’s Exosome Purification Kits avoid ultracentrifugation and PEG precipitation via our proprietary isolation technology that targets the charge of exosomal surface proteins.
NORBLOG
Want to hear more from Norgen?
Join over 10,000 scientists, bioinformaticians, and researchers who receive our exclusive deals, industry updates, and more, directly to their inbox.
For a limited time, subscribe and SAVE 10% on your next purchase!
SIGN UP